Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise (EXETOR)

This study has been terminated.
(lack of potential patients)
Information provided by (Responsible Party):
Josep M Cruzado, Hospital Universitari de Bellvitge Identifier:
First received: March 20, 2012
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)